The feasibility and efficacy of subcutaneous plerixafor for mobilization of peripheral blood stem cells in allogeneic HLA–identical sibling donors: results of the HOVON‐107 study...

por de Greef, Georgine E., Braakman, Eric, van der Holt, Bronno, Janssen, Jeroen J.W.M., Petersen, Eefke, Vucinic, Vladimir, Thuss, Nicole, Grootes, Meriam, Cornelissen, Jan J.
Publicado 2018

Nitric oxide production and monoamine oxidase activity in cancer patients during interferon-α therapy

por Fekkes, Durk, Van Gool, Arthur R., Bannink, Marjolein, Sleijfer, Stefan, Kruit, Wim H. J., van der Holt, Bronno, Eggermont, Alexander M. M., Hengeveld, Michiel W., Stoter, Gerrit
Publicado 2008

Tumor Volume as an Alternative Response Measurement for Imatinib Treated GIST Patients

por Schiavon, Gaia, Ruggiero, Alessandro, Schöffski, Patrick, van der Holt, Bronno, Bekers, Dave J., Eechoute, Karel, Vandecaveye, Vincent, Krestin, Gabriel P., Verweij, Jaap, Sleijfer, Stefan, Mathijssen, Ron H. J.
Publicado 2012

Correction: Tumor Volume as an Alternative Response Measurement for Imatinib Treated GIST Patients

por Schiavon, Gaia, Ruggiero, Alessandro, Schöffski, Patrick, van der Holt, Bronno, Bekers, Dave J., Eechoute, Karel, Vandecaveye, Vincent, Krestin, Gabriel P., Verweij, Jaap, Sleijfer, Stefan, Mathijssen, Ron H. J.
Publicado 2013

V-Domain Ig Suppressor of T Cell Activation (VISTA) Expression Is an Independent Prognostic Factor in Multiple Myeloma

por Mutsaers, Pim, Balcioglu, Hayri E., Kuiper, Rowan, Hammerl, Dora, Wijers, Rebecca, van Duin, Mark, van der Holt, Bronno, Broijl, Annemiek, Gregory, Walter, Zweegman, Sonja, Sonneveld, Pieter, Debets, Reno
Publicado 2021

Pomalidomide in Patients With Relapsed and/or Refractory Multiple Myeloma: A Prospective Study Within the Nationwide Netherlands Cancer Registry

por Wester, Ruth, Dinmohamed, Avinash G., van der Holt, Bronno, Zweegman, Sonja, Minnema, Monique, Croockewit, Sandra, Levin, Mark-David, Libourel, Eduard, de Waal, Esther, Sonneveld, Pieter, Cornelissen, Jan, Blijlevens, Nicole, Broijl, Annemiek
Publicado 2022

CD34-related coexpression of MDR1 and BCRP indicates a clinically resistant phenotype in patients with acute myeloid leukemia (AML) of older age

por van den Heuvel-Eibrink, Marry M., van der Holt, Bronno, Burnett, Alan K., Knauf, Wolfgang U., Fey, Martin F., Verhoef, Gregor E. G., Vellenga, Edo, Ossenkoppele, Gert J., Löwenberg, Bob, Sonneveld, Pieter
Publicado 2007

Carfilzomib Combined With Thalidomide and Low-dose Dexamethasone for Remission Induction and Consolidation in Newly Diagnosed Transplant Eligible Patients With Multiple Myeloma: 8...

por Wester, Ruth, Zweegman, Sonja, van der Holt, Bronno, Kersten, Marie José, Vellenga, Edo, van Marwijk-Kooy, Marinus, Asselbergs, Emelie, de Weerdt, Okke, Minnema, Monique C., Lonergan, Sarah, Palumbo, Antonio, Broijl, Annemiek, Sonneveld, Pieter
Publicado 2020

Phase II study of carfilzomib, thalidomide, and low-dose dexamethasone as induction and consolidation in newly diagnosed, transplant eligible patients with multiple myeloma; the Ca...

por Wester, Ruth, van der Holt, Bronno, Asselbergs, Emelie, Zweegman, Sonja, Kersten, Marie Jose, Vellenga, Edo, van Marwijk Kooy, Marinus, de Weerdt, Okke, Minnema, Monique, Lonergan, Sarah, Palumbo, Antonio, Lokhorst, Henk, Broijl, Annemiek, Sonneveld, Pieter
Publicado 2019

The impact of different volumetric thresholds to determine progressive disease in patients with recurrent glioblastoma treated with bevacizumab

por Gahrmann, Renske, Smits, Marion, Vernhout, René Michel, Taal, Walter, Kapsas, Giorgios, de Groot, Jan Cees, Hanse, Monique, Vos, Maaike, Beerepoot, Laurens Victor, Buter, Jan, Flach, Zwenneke Hendrieke, van der Holt, Bronno, van den Bent, Martin
Publicado 2022

Posttransplant cyclophosphamide for prevention of graft-versus-host disease: results of the prospective randomized HOVON-96 trial

por Broers, Annoek E. C., de Jong, Cornelis N., Bakunina, Katerina, Hazenberg, Mette D., van Marwijk Kooy, Marinus, de Groot, Marco R., van Gelder, Michel, Kuball, Jürgen, van der Holt, Bronno, Meijer, Ellen, Cornelissen,, Jan J.
Publicado 2022

Music to prevent deliriUm during neuroSurgerY (MUSYC): a single-centre, prospective randomised controlled trial

por Kappen, Pablo R, Mos, M I, Jeekel, Johannes, Dirven, Clemens M F, Kushner, Steven A, Osse, Robert-Jan, Coesmans, Michiel, Poley, Marten J, van Schie, Mathijs S, van der Holt, Bronno, Klimek, M, Vincent, Arnaud J P E
Publicado 2023

(18)F-FDG PET baseline radiomics features improve the prediction of treatment outcome in diffuse large B-cell lymphoma

por Eertink, Jakoba J., van de Brug, Tim, Wiegers, Sanne E., Zwezerijnen, Gerben J. C., Pfaehler, Elisabeth A. G., Lugtenburg, Pieternella J., van der Holt, Bronno, de Vet, Henrica C. W., Hoekstra, Otto S., Boellaard, Ronald, Zijlstra, Josée M.
Publicado 2021

Comparing lesion and feature selections to predict progression in newly diagnosed DLBCL patients with FDG PET/CT radiomics features

por Eertink, Jakoba J., Zwezerijnen, Gerben J. C., Cysouw, Matthijs C. F., Wiegers, Sanne E., Pfaehler, Elisabeth A. G., Lugtenburg, Pieternella J., van der Holt, Bronno, Hoekstra, Otto S., de Vet, Henrica C. W., Zijlstra, Josée M., Boellaard, Ronald
Publicado 2022

Avoiding Tacrolimus Underexposure and Overexposure with a Dosing Algorithm for Renal Transplant Recipients: A Single Arm Prospective Intervention Trial

por Francke, Marith I., Andrews, Louise M., Le, Hoang Lan, van de Wetering, Jacqueline, Clahsen‐van Groningen, Marian C., van Gelder, Teun, van Schaik, Ron H. N., van der Holt, Bronno, de Winter, Brenda C. M., Hesselink, Dennis A.
Publicado 2021

Protocol for the STRONG trial: stereotactic body radiation therapy following chemotherapy for unresectable perihilar cholangiocarcinoma, a phase I feasibility study

por Koedijk, Merel S, Heijmen, Ben J M, Groot Koerkamp, Bas, Eskens, Ferry A L M, Sprengers, Dave, Poley, Jan-Werner, van Gent, Dik C, van der Laan, Luc J W, van der Holt, Bronno, Willemssen, François E J A, Méndez Romero, Alejandra
Publicado 2018

The added value of multi‐state modelling in a randomized controlled trial: The HOVON 102 study re‐analyzed

por Bakunina, Katerina, Putter, Hein, Versluis, Jurjen, Koster, Eva A. S., van der Holt, Bronno, Manz, Markus G., Breems, Dimitri A., Gjertsen, Bjorn T., Cloos, Jacqueline, Valk, Peter J. M., Passweg, Jakob, Pabst, Thomas, Ossenkoppele, Gert J., Löwenberg, Bob, Cornelissen, Jan J., de Wreede, Liesbeth C.
Publicado 2021

Clonal evolution after treatment pressure in multiple myeloma: heterogenous genomic aberrations and transcriptomic convergence

por Misund, Kristine, Hofste op Bruinink, Davine, Coward, Eivind, Hoogenboezem, Remco M., Rustad, Even Holth, Sanders, Mathijs A., Rye, Morten, Sponaas, Anne-Marit, van der Holt, Bronno, Zweegman, Sonja, Hovig, Eivind, Meza-Zepeda, Leonardo A., Sundan, Anders, Myklebost, Ola, Sonneveld, Pieter, Waage, Anders
Publicado 2022

Gene Expression Profile Alone Is Inadequate In Predicting Complete Response In Multiple Myeloma

por Amin, Samirkumar B., Yip, Wai-Ki, Minvielle, Stephane, Broyl, Annemiek, Li, Yi, Hanlon, Bret, Swanson, David, Shah, Parantu K., Moreau, Philippe, van der Holt, Bronno, van Duin, Mark, Magrangeas, Florence, Sonneveld P., Pieter, Anderson, Kenneth C., Li, Cheng, Avet-Loiseau, Herve, Munshi, Nikhil C.
Publicado 2014

Exploratory Study of Predicted Indirectly ReCognizable HLA Epitopes in Mismatched Hematopoietic Cell Transplantations

por Geneugelijk, Kirsten, Thus, Kirsten A., van Deutekom, Hanneke W. M., Calis, Jorg J. A., Borst, Eric, Keşmir, Can, Oudshoorn, Machteld, van der Holt, Bronno, Meijer, Ellen, Zeerleder, Sacha, de Groot, Marco R., von dem Borne, Peter A., Schaap, Nicolaas, Cornelissen, Jan, Kuball, Jürgen, Spierings, Eric
Publicado 2019